BREAST CANCER
May 15, 2020
A Review of CDK4/6 Inhibitors
CDK4/6 inhibitors are able to block cell-cycle progression in the middle of the G1 phase and prevent cancer cell progression.September 19, 2019
Breast Cancer
August 27, 2019
CAM Interactions in Breast and Other Gynecological Cancers
August 22, 2019
Metabolic Changes May Predict Anthracycline Cardiotoxicity
August 21, 2019
Updated Nomogram Assesses Recurrence Risk
August 21, 2019
Genome-Wide Association Study of Anastrozole Therapy
August 14, 2019
Effect of Transgender Status on Breast-Cancer Risk
Copyright © 2000 - 2020 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.